Please enable JavaScript.

Coggle requires JavaScript to display documents.

EPQ, Grade 1-2 Muscle and Joint Pain, Grade 1-3 Nausea and Vomiting, Grade…

- - - - Parent companies
        
        Atezolizumab
        
        PDL-1 inhibitor
        
        Avelumab
        
        PDL-1 inhibitor
        
        Nivolumab
        
        PDL-1 inhibitor
        
        durvalumab
        
        PDL-1 inhibitor
        
        Isatuximab
        
        Anti CD-38 monoclonal antibody
        
        Tremelimumab
        
        CTLA-4 inhibitor
        
        Daratumumumab
        
        Anti CD-38 monoclonal antibody
        
        Nedaplatin
        
        Intravenous antineoplastic
        
        PMDA approved 1995
        
        Lobaplatin
        
        Intravenous antineoplastic
        
        NMPA approved unknown
        
        Oxaliplatin
        
        Intravenous chemotherapy
        
        FDA approved 09/01/04
        
        Heptaplatin
        
        Intravenous chemotherapy
        
        MFDS approved unknown
        
        Carboplatin
        
        Intravenous chemotherapy
        
        FDA approved 03/03/89
        
        Cisplatin
        
        Intravenous chemotherapy
        
        FDA approved 19/12/78
        
        Satraplatin
        
        Intravenous chemotherapy
        
        FDA approved 1978, SINCE BEEN REMOVED
        
        Side Effects
        
        Common Terminology Criteria for Adverse Events
        
        Immune checkpoints
        
        Chemotherapies
  - - - Use to get clinical trials that are both in progress and finished. Gives results for free and allows for specific searchs
      - Trusted source used in Healthcare
    - - Needs account
      - Ultra specified
      - Gives primary researcher contact info
    - - Company endorsed clinical trials
        
        (possibly biased)
  - - - CTCAE
        
        Common Terminology Criteria for Adverse Events
      - ACS
        
        American Cancer Society
      - SITC
        
        Society for ImmunoTherapy of Cancer
      - WHO
        
        World Health Organisation
      - ESMO
        
        European Society for Medical Oncology
- - - - Chemotherapies
      - Immune Checkpoints
    - - Chemotherapies
      - Immune Checkpoints